Company Filing History:
Years Active: 2003
Title: Kalev Kask: Innovator in Neurological Diagnostics
Introduction: Kalev Kask is an accomplished inventor based in San Mateo, CA, known for his contributions to the field of neurological diagnostics. With two patents to his name, Kask’s research focuses on advancing the understanding and treatment of brain conditions through innovative methodologies and reagents.
Latest Patents: Kalev Kask's latest patents reflect his commitment to enhancing diagnostics for neurological conditions. His first patent, titled "Diagnostic marker for neurological conditions," involves a human phospholipase C expressed in the brain (B-PLC) that is induced in response to ischemic brain tissue. This invention provides pivotal methods and reagents useful for diagnosing and treating hypoxic-ischemic brain insults, such as stroke. His second patent, "Methods for identifying a modulator of the interaction of NMDA receptor with protein tyrosine phosphatase L1," identifies a binding between NMDA receptor (NMDA-R) subunits and a protein tyrosine phosphatase (PTP). This patent offers innovative methods for screening PTPL1 agonists or antagonists that modulate NMDA-R signaling, alongside methods and compositions for treating disorders linked to abnormal NMDA-R signaling.
Career Highlights: Kalev Kask is currently affiliated with Agy Therapeutics, Inc., where he applies his expertise in neurological research and innovation. His significant contributions to the development of tools for diagnosing and treating brain conditions have marked him as a prominent figure in his field.
Collaborations: Kask collaborates with notable colleagues, including Thorsten Melcher and Daniel J. Chin. Together, they work on furthering research and enhancing therapeutic strategies in neurology.
Conclusion: With his innovative approaches and important patents in neurological diagnostics, Kalev Kask is making a substantial impact on the medical field. His ongoing work at Agy Therapeutics, Inc. and collaborations with esteemed colleagues continue to push the boundaries of what is possible in the diagnosis and treatment of neurological conditions.